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The signalling lipid PI(3,5)P2 is generated on endosomes
and regulates retrograde trafﬁc to the trans-Golgi network.
Physiological signals regulate rapid, transient changes in
PI(3,5)P2 levels. Mutations that lower PI(3,5)P2 cause
neurodegeneration in human patients and mice. The func-
tion of Vac14 in the regulation of PI(3,5)P2 was unchar-
acterized previously. Here, we predict that yeast and
mammalian Vac14 are composed entirely of HEAT repeats
and demonstrate that Vac14 exerts an effect as a scaffold
for the PI(3,5)P2 regulatory complex by direct contact with
the known regulators of PI(3,5)P2: Fig4, Fab1, Vac7 and
Atg18. We also report that the mouse mutant ingls
(infantile gliosis) results from a missense mutation in
Vac14 that prevents the association of Vac14 with Fab1,
generating a partial complex. Analysis of ingls and two
additional mutants provides insight into the organization
of the PI(3,5)P2 regulatory complex and indicates that
Vac14 mediates three distinct mechanisms for the rapid
interconversion of PI3P and PI(3,5)P2. Moreover, these
studies show that the association of Fab1 with the complex
is essential for viability in the mouse.
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Introduction
Phosphoinositide phosphate (PIP) lipids are transiently gen-
erated on the cytoplasmic face of selected intracellular mem-
branes. Spatial localization of the lipid kinases and
phosphatases that generate speciﬁc PIPs produces unique
PIP tags on different membrane compartments (Matteis and
Godi, 2004; Behnia and Munro, 2005; Bolis et al, 2007). PIPs
function through recruitment of speciﬁc effector proteins,
which in turn regulate ion channels, membrane ﬁssion and
fusion, and formation of membrane tubules. PI(3,5)P2 is
synthesized by phosphorylation of PI3P. Both PI3P and
PI(3,5)P2 are generated in the endomembrane system, a
heterogeneous system of membranes involved in trafﬁc to
and from the plasma membrane, the lysosome, and the Golgi
(Di Paolo and De Camilli, 2006). PI(3,5)P2 is a minor PIP
present at o0.1 and o0.05% of total PI lipids in yeast and
mammalian cells, respectively, compared with the more
typical values of 2.5 and 0.2% for PI3P (Bonangelino et al,
2002; Duex et al, 2006b; Zhang et al, 2007).
The dynamic interconversion of PI3P and PI(3,5)P2 is
regulated by at least ﬁve proteins in yeast: the lipid kinase
Fab1p, lipid phosphatase Fig4p, the Fab1p activator Vac7p,
the Fab1p inhibitor Atg18p, and Vac14p, a protein required
for the activity of both Fab1p and Fig4p (Bonangelino et al,
1997, 2002; Gary et al, 1998, 2002; Dove et al, 2002, 2004;
Rudge et al, 2004; Duex et al, 2006a,b; Efe et al, 2007).
Homologues of Fab1p, Vac14p and Fig4p are found in all
eukaryotes. In yeast, Vac14p, Fab1p and Fig4p are localized
on the vacuole membrane (Bonangelino et al, 2002; Dove
et al, 2004; Rudge et al, 2004; Duex et al, 2006a) and form a
complex (Botelho et al, 2008). In mammalian cells, these
proteins, also known as Fab1/PIKfyve/PIP5K3, Fig4/Sac3,
and Vac14/ArPIKfyve, are located on early and late endo-
somes (Ikonomov et al, 2006; Rutherford et al, 2006).
Association of the three mammalian proteins in cultured
cells has been demonstrated by coimmunoprecipitation and
cosedimentation (Sbrissa et al, 2007). Genetic analysis in
yeast shows that Vac14p is required for Fab1p and Fig4p
function (Bonangelino et al, 1997; Duex et al, 2006b), but the
mechanism of this regulation is not known.
We recently described lethal null mutations of mammalian
Vac14 and Fig4 that revealed the critical function of PI(3,5)P2
for neuronal survival. A null mutation of Fig4 in the pale
tremor mouse results in the formation of vacuoles in the cell
bodies of neurons of the central nervous system (CNS) and
peripheral nervous system, with extensive degeneration of
sensory neurons of the dorsal root ganglia (DRG) and juve-
nile lethality around the time of weaning (Chow et al, 2007).
A null mutation of Vac14 results in perinatal lethality with
extensive degeneration of DRG neurons (Zhang et al, 2007).
The level of PI(3,5)P2 is reduced by approximately 50% in
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3221cultured ﬁbroblasts from both mutants. The increased sensi-
tivity of neurons to mutations causing PI(3,5)P2 deﬁciency
could result from the high rate of membrane turnover re-
quired for maintenance of axonal and dendritic processes
(Volpicelli-Daley and De Camilli, 2007). Vacuoles that contain
the late endosome/lysosome marker LAMP-2 accumulate in
cells deﬁcient in Fig4, Vac14 or Fab1 (Ikonomov et al, 2006;
Rutherford et al, 2006; Chow et al, 2007; Zhang et al, 2007),
suggesting that failure to resolve late endosomal vesicles may
be responsible for vacuole accumulation. Human patients
who are compound heterozygotes for missense and null
mutations of Fig4 are affected by Charcot–Marie–Tooth type
4J, a severe peripheral neuronopathy (Chow et al,2 0 0 7 ;
Zhang et al, 2008).
The ingls mouse, a spontaneous neurological mutant with
autosomal recessive inheritance, arose at the Jackson
Laboratory in 1991 (Bronson et al, 2003). We now report
that a missense mutation of a conserved leucine residue in
Vac14 is the molecular defect in ingls. As the ingls mouse
survives for up to 3 weeks after birth, postnatal phenotypes
caused by defective Vac14 function could be characterized.
Examination of the corresponding mutation in yeast vac14,
combined with analysis of additional partially functional
mutants of yeast vac14 and fab1, led to the determination
that Vac14 nucleates the PI(3,5)P2 regulatory complex. The
mutants led to the identiﬁcation of speciﬁc regions of the
Vac14 protein required for interaction with proteins in the
complex. We also demonstrate that two additional regulators
of the Fab1 kinase, Vac7p and Atg18p, reside within the
complex. We ﬁnd that formation of the complex is essential
for the osmotic-stress-induced activation of Fab1. Analysis of
the new vac14 and fab1 mutants provides insights into the
organization of the PI(3,5)P2 regulatory complex and its
crucial function in the mammalian nervous system.
Results
Phenotype of the ingls mouse
The spontaneous mutation ingls (infantile gliosis) arose on
the DBA/2J strain background and has been maintained by
23 generations of backcrossing to strain C57BL/6J to generate
the congenic line B6. ingls. Homozygous ingls mutants
exhibit reduced body size and diluted pigmentation that
can be recognized as early as postnatal day 3 (P3)
(Figure 1A). By P14, the mice exhibit a tremor and impaired
motor function (Supplementary video). The frequency of
affected offspring born from crosses between heterozygous
carriers is consistent with Mendelian expectation (29/140,
P¼0.24). However, the maximal survival for ingls/ingls
homozygotes is 3 weeks, with continuous losses between
P1 and P21. Histological analysis of the brain revealed greatly
enlarged ventricles (Figure 1B, middle panel). Small areas
with the appearance of spongiform degeneration are visible
in several brain regions, including the thalamus, brain stem
and cerebellar nucleus (Supplementary Figure S1A). This
pattern resembles the more widespread degeneration in the
Fig4-null mouse (Chow et al, 2007). However, spinal motor
neurons and sensory neurons in the DRG remain intact
during the lifetime of the ingls mutant (Supplementary
Figure S1B). Intense staining for glial ﬁbrillary acidic protein
(GFAP) is evident throughout the ingls brain, suggesting
widespread astrogliosis (Figure 1C and Supplementary
Figure S2A). GFAP is sufﬁciently increased to be detected
by western blot of cortical extracts (Supplementary Figure
S2B). Increased GFAP staining is evident as early as E14.5
(not shown).
Genetic mapping of ingls
The ingls mutation was ﬁrst mapped to an 18Mb interval on
distal mouse chromosome 8, between microsatellite markers
D8Mit86 and D8Mit88, by genotyping 31 affected F2 offspring
from a cross between DBA/2J.ingls/þ and C57BL/6J (Bronson
et al, 2003). Genotyping additional markers on chromosome 8
reduced the nonrecombinant region to a 5.7Mb interval with
the following gene order: SNP1 (111.6Mb)—1/62—ingls—
1/62—D8Mit88 (117.3Mb) (Supplementary Figure S3A). This
nonrecombinant region contains 63 annotated genes (Mouse
Build 37.2, www.ensembl.org).
Identiﬁcation of a mutation in Vac14
The Vac14 gene spans the region between 113.1 and 113.2Mb
on chromosome 8, within the ingls nonrecombinant region.
Based on similarities between the ingls phenotype and null
mutations of Vac14 and Fig4 (Chow et al, 2007; Zhang et al,
2007), we tested Vac14 as a candidate gene for ingls.
The 19 exons of Vac14 were ampliﬁed from genomic DNA
of an affected ingls homozygote and sequenced. Comparison
with the wild-type sequence from strain C57BL/6J (Build
37.2, www.genome.ucsc.edu) identiﬁed the nucleotide sub-
stitution c.467T4G in exon 4 (Figure 1D). Strain DBA/2J, the
strain of origin of the ingls mutation, contains the wildtype
residue (not shown). The T4G substitution destroys a SacI
endonuclease site, which was used to genotype the Vac14
ingls
allele. The mutation results in substitution of an arginine
residue for the evolutionarily invariant residue leucine 156
(Figure 1E). Western blot analysis of brain extracts revealed
normal abundance of Vac14 protein in the mutant brain
(Figure 1F).
Noncomplementation of ingls and a Vac14-null allele
To conﬁrm the causal function of the Vac14-L156R mutation
in the ingls phenotype, we assessed the ability of the
Vac14
ingls allele to complement the recessive lethality of
the null allele Vac14
b geo (Vac14
 ) (Zhang et al, 2007).
Heterozygous ingls mice (Vac14
þ/ingls) were crossed with
null heterozygotes (Vac14
þ/ ). The Vac14
ingls/  compound
heterozygotes were born in the predicted Mendelian ratio of
25% but did not survive to weaning, showing that ingls is
allelic with the null allele (Supplementary Figure S3B). The
compound heterozygotes reproduced the phenotype of the
ingls homozygote, with reduced body size and diluted pig-
mentation (Figure 1A), as well as enlarged ventricles
(Figure 1B). The phenotypic similarity between Vac14
ingls/ 
compound heterozygotes and ingls homozygotes, the failure
of the ingls allele to rescue the null homozygote, and the
mapping of ingls to an interval of chromosome 8 that
includes Vac14, support the identiﬁcation of Vac14-L156R
as the ingls mutation. The survival of the compound hetero-
zygotes to P14, compared with the neonatal lethality of null
homozygotes, shows that the Vac14
L156R allele retains partial
function.
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ingls ﬁbroblasts
Levels of phosphoinositide lipids were assessed in
cultured ingls ﬁbroblasts. In wild-type ﬁbroblasts, PI(3,5)P2
comprised 0.04% of total PI. In mutant ingls ﬁbroblasts,
PI(3,5)P2 was reduced to 50% of normal, whereas the
levels of PI3P, PI4P and PI(4,5)P2 were unaffected
(Figure 1G).
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Figure 1 ingls is caused by the missense mutation Vac14–L156R.( A) ingls homozygous mice at postnatal day 14 (P14) display reduced body
weight and diluted coat colour. ingls/Vac14
  compound heterozygotes at P14 are similar in appearance. (B) Severe hydrocephalus and enlarged
ventricles in ingls homozygote (P16) and ingls/Vac14
  compound heterozygotes (P14) (H&E staining). (C) GFAP-stained astrocytes in neonatal
ingls- and Vac14-null mice. (D) Sequence chromatogram from exon 4 of an ingls/þ heterozygote demonstrates the c467 T4G nucleotide
substitution. (E) The ingls mutation changes leucine 156 to arginine. Leucine 156 is evolutionarily invariant from yeast to mammals. Dots
indicate amino-acid identity with human Vac14. (F) Western blot of Vac14 protein in brain extracts of wild-type and ingls mice. Loading
control, GAPDH. (G) Reduced levels of PI(3,5)P2 in cultured ﬁbroblasts from ingls mice. (H, I) Rescue of vacuole formation by wild-type human
Vac14 cDNA. Primary ﬁbroblasts from ingls mice transfected with the indicated plasmids. At 24h, cells were ﬁxed with 4% paraformaldehyde
in PBS for 10min, room temperature. (H). Fluorescent cells were scored for the presence of vacuoles. Mean±s.d. for three independent
experiments, 4100 cells per experiment. (I) Representative cells are shown; arrows mark transfected cells. Bar, 20mm.
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cuoles in the cultured ﬁbroblasts from ingls mice (Figure 1I,
bottom). The vacuolated appearance of the ingls ﬁbroblasts is
similar to the ﬁbroblasts from Vac14- and Fig4-null mice,
indicating that the reduced level of PI(3,5)P2 is responsible
for the similarity (Chow et al, 2007; Zhang et al, 2007).
Transfection of a construct expressing a wild-type human
Vac14–mCit fusion protein reduced the frequency of vacuo-
lized ingls ﬁbroblasts from 20 to 5% (Figure 1H and 1I).
Correction by wild-type Vac14 shows that the Vac14–L156R
mutation is responsible for the ingls cellular phenotype. The
stability of the mutant protein in vivo indicates that the
Vac14–L156R protein is functionally impaired.
Prediction that Vac14 is composed entirely of HEAT
repeats places the L156R mutation in repeat 4
HEATrepeats contain two anti-parallel helices connected by a
short loop. These units often appear as a tandem series and
provide surfaces for protein–protein interactions (Groves
et al, 1999; Andrade et al, 2000). Previous analysis of the
Vac14p sequence identiﬁed 1–3 HEAT repeats (Dove et al,
2002). As HEAT repeat sequences are degenerated, many
bona ﬁde repeats are not detected by motif detection pro-
grams.
Analysis of the Vac14 protein sequence with the repeat
ﬁnding program REP set at a conﬁdence threshold of
Pyo1e 6 (http://www.embl-heidelberg.de/~andrade/pa-
pers/rep/search.html) (Andrade et al, 2000) predicted eight
HEAT repeats in the Saccharomyces cerevisiae Vac14p se-
quence. One additional repeat was identiﬁed by REP in
Drosophila melanogaster and Schizosaccharomyces pombe
sequences and, by sequence similarity, was found in the S.
cerevisiae sequence. A second analysis incorporated Vac14p
sequences from 17 diverse species. Predicted HEAT repeats
were deﬁned by three criteria: (1) identiﬁcation by REP in one
or more species using no conﬁdence threshold; (2) secondary
structure prediction of two helices connected by a short loop;
(3) alignment by visual inspection with HEAT repeat con-
sensus sequences from the Pfam database. This analysis
identiﬁed 21 potential HEAT repeats in S. cerevisiae Vac14p
(Figure 2A). Many exhibit sequence similarity in all 17
species (not shown). Yeast Vac14p is thus most likely to
contain a minimum of 9 HEAT repeats and as many as 21
repeats, which would comprise the entire protein. Analysis of
human Vac14 predicted 17 repeats, 15 of which have homo-
logues in S. cerevisiae Vac14p. The L156R mutation is located
in helix B of HEAT repeat 4 (Figure 2A). A similar analysis
accurately predicted the 50 HEATrepeats of TOR1 (Perry and
Kleckner, 2003).
The L156R mutation disrupts Vac14 interaction with
Fab1 but not Fig4
HEAT repeat proteins usually function as scaffolds with
multiple binding partners (Groves et al, 1999; Andrade
et al, 2000). The prediction that Vac14 may be composed
entirely of HEAT repeats suggested that Vac14 may bind
proteins that regulate PI(3,5)P2 levels. Previous sedimenta-
tion and coimmunoprecipitation analysis demonstrated that
mammalian Vac14, Fab1, and Fig4 associate with each other
(Sbrissa et al, 2007). We tested potential interactions using
the yeast two-hybrid test and found that human Vac14
interacts with Fab1 and Fig4 (Figure 2B). The ingls mutation,
Vac14-L156R, speciﬁcally disrupts the interaction between
Vac14 and Fab1 but retains interaction with Fig4
(Figure 2B). A third interaction of yeast Vac14p is self-
association (Dove et al, 2002). We ﬁnd that human Vac14
also interacts with itself and this interaction is unaffected by
the Vac14–L156R mutation (Figure 2B). These data suggest
that disruption of the interaction between Fab1 and Vac14 is
the molecular basis for the ingls mutant phenotype.
Vac14p interacts with the known protein regulators of
PI(3,5)P2
To determine whether Vac14p interacts with the other pro-
teins known to regulate PI(3,5)P2 levels, we tested Vac7p and
Atg18p, two additional regulators of yeast Fab1p. As Fab1p
and Vac7p are large proteins, we performed a yeast two-
hybrid test with constructs that expressed overlapping pep-
tides from conserved regions of Fab1p and Vac7p. We found
that Fab1p peptide 538–1085 and Vac7p peptide 394–918
interacted with yeast Vac14p in the yeast two-hybrid test
(Figure 2C). Vac14p also interacts with full-length constructs
of Fig4p and Atg18p and with itself (Figure 2C).
To determine whether each protein colocalizes with
Vac14p in vivo, we generated a chromosomal integrant of a
Vac14p fusion construct containing the ﬂuorescent tag RFP–
mCherry. Consistent with the yeast two-hybrid studies,
Vac14p–mCherry colocalized on the vacuole membrane
with GFP- or Venus-tagged Fab1p, Fig4p, Vac7p, and Atg18p
(Supplementary Figure S5).
Fab1 and its regulators reside within a large protein
complex
Coimmunoprecitation experiments were performed to test
the model that Vac14p nucleates a large complex
(Figure 2D). Using the tagged proteins Vac14p–HA and
Vac14p–V5, we found that immunoprecipitation with anti-
HA antibody coprecipitated Vac14p–V5 (Supplementary
Figure S4A). Furthermore, Fab1p containing a C-terminal
tandem afﬁnity puriﬁcation (TAP) tag (Fab1–TAP) coprecipi-
tated Vac14p–V5 (Supplementary Figure S4B). Moreover,
immunoprecipitation of Vac14p coprecipitates Fig4p
(Supplementary Figure S4C). In addition, precipitation of
Fig4p coprecipitates Fab1p (Supplementary Figure S4D).
These interactions were reported independently (Rudge
et al, 2004; Botelho et al, 2008), and it was proposed that
Fab1p, Vac14p, and Fig4p form a ternary complex (Botelho
et al, 2008).
Immunoprecipitation of Vac14p–Venus also coprecipitates
Vac7p (Figure 2E). These coprecipitation experiments demon-
strate that Vac14p interacts with itself, Fab1p, Fig4p, and
Vac7p. We did not observe coprecipitation of Atg18p with
Vac14p, Fab1p-TAP, or Vac7p (not shown).
To determine whether the proteins form a large complex,
we used sedimentation analysis of detergent solubilized yeast
cell lysates. When lysates were fractionated on a 10–50%
glycerol gradient, Fab1 was distributed in two peaks
(Figure 2F). The smaller peak, fraction 3, contained mono-
meric Fab1p (predicted molecular weight 257kDa). The
larger peak, fractions 6–8, contained Fab1p in a complex
that sediments more slowly than the 670kDa molecular
weight standard in fractions 4 and 5. Although the predicted
molecular weights of Vac7p, Fig4p, and Vac14p are 128, 101,
and 99kDa, respectively, signiﬁcant proportions of these
VAC14 complex in yeast and ingls mouse
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in fractions 6 and 7; Fig4p, in fractions 6–8; and Vac14p, in
fractions 5–8. That the peak fractions for Fab1p, Vac7p,
Fig4p, and Vac14p overlap but are not identical may be
explained by the presence of a mixture of partial and com-
plete complexes. For example, the ternary complex of Fab1p,
Vac14p, and Fig4p is found exclusively on the membrane of
the vacuole, whereas Vac14p and Fig4p associate with each
other in the cytosol (Botelho et al, 2008).
Most of the Atg18p (55kDa) behaved as a monomer
(fractions 1 and 2), but some Atg18p comigrated
with the complex (fractions 5–7), suggesting that this small
fraction is also part of the complex. Alternatively, the
Atg18 in fraction 6 could be trailing from the earlier
fractions. However, note that the intensity of fraction 6 is
the same as fraction 5. Genetic evidence (below) strongly
suggests that a portion of Atg18p is part of the Vac14p
complex. Atg18p has a second distinct function in autophagy
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Figure 2 Vac14 nucleates the Fab1 complex. (A) Vac14 contains 21 and 17 HEATrepeats in S. cerevisiae (top) and mammalian Vac14 (bottom),
respectively. Identical colours indicate homologous repeats between S. cerevisiae and mammalian Vac14. Red asterisk and blue arrows indicate
ingls and vac14-2 mutations, respectively. Underlines: HEAT repeats identiﬁed by REP with a conﬁdence threshold better than at Pyo1e 6.
(B) Yeast two-hybrid test of human Vac14 (HsVac14) or human Vac14–L156R (HsVac14-L4R), fused with the GAL4-activation domain (AD),
interaction with itself, residues 346–1134 of human Fab1 or full-length Fig4, fused with the GAL4-binding domain (BD). Plasmids were
cotransformed into the yeast cells and transformants were plated onto the SC-LEU-TRP plate and replica-plated onto SC-LEU-TRP (control) or
SC-LEU-TRP-ADE-HIS plate (test). Plates were incubated at 241C for 10 days. Growth on the test plate indicates protein–protein interaction.
(C) Yeast two-hybrid test of Gal4-AD fused with yeast Vac14p tested with Gal4-BD fused with either Fab1p, Fig4p, Vac7p, Atg18p or Vac14p.
Transformants were plated onto SC-LEU-TRP and replica-plated onto SC-LEU-TRP (control) or SC-LEU-TRP-ADE-HISþ3AT (test). Plates were
incubated at 241C for 7 days. (D) Schematic of interactions between Fab1 and Fab1 regulators. (E) Vac14p–Venus coprecipitated Vac7p. Wild-
type or VAC14–Venus cells were used. (F) Analysis on glycerol gradients (10–50%) indicate that Fab1p and regulators form a complex
4670kDa. Molecular weight markers bovine serum albumin, 66kDa, and thyroglobulin, 670kDa, run in an adjacent tube. Representative
proﬁle of two independent gradients. vac14D/ﬁg4D/ATG18–Venus cells expressing pRS413–VAC14–V5 and pRS415–FIG4–Myc were used.
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related to that function.
The above-mentioned results are consistent with the
model that Vac14p nucleates a large complex containing
Fab1p, Fig4p, Vac7p, Vac14p, and possibly Atg18p. Rather
than pursuing analysis of the complex through further
biochemical investigations, we identiﬁed and characterized
mutations that partially disrupt the complex as a means to
determine the functional signiﬁcance of complete and partial
complexes, and also map the interacting domains.
Fab1p, Vac14p, and Fig4p are required to form the core
PI(3,5)P2 regulatory complex
Fab1p does not interact with Fig4p in a yeast two-hybrid test.
However, Fab1p–TAP coprecipitates with Fig4p, suggesting
that the two proteins could interact indirectly. Indeed, co-
precipitation of Fig4p by Fab1p–TAP required the presence
of Vac14p and did not occur in the vac14D strain
(Supplementary Figure S4E). Unexpectedly, coprecipitation
of Fab1p–TAP with Vac14p required the presence of Fig4p
(Supplementary Figure S4F). These data indicate that Fab1p
requires both Vac14p and Fig4p to form a ternary complex
in vivo. Localization experiments indicate that formation of
the ternary complex is required for normal localization of
members of the complex to the vacuole membrane
(Figure 3A and B). Note that in each mutant, vac14D,
ﬁg4D, and fab1D, there is mislocalization to the cytoplasm
of signiﬁcant amounts of the remaining members of the
complex.
Vac7p binds Vac14p in yeast two-hybrid and coimmuno-
precipitation experiments (Figure 2C and 2E). To determine
whether Vac7p is required for formation of the Fab1p/
Vac14p/Fig4p complex, we carried out coprecipitation experi-
ments in vac7D cells. Interaction of Fab1p with Vac14p
(Supplementary Figure S6A) and Fig4p (Supplementary
Figure S6B) did not require Vac7p. Localization of Fig4p,
Vac14p, and Fab1p to the vacuolar membrane was indepen-
dent of Vac7p (Supplementary Figure S6C). Similarly, Vac7p
localization to the vacuole membrane is independent of
Vac14p and Fig4p (Supplementary Figure S6C). Although
two-hybrid studies support the proposal that Atg18p is part
of the complex, this was not observed by coprecipitation. To
further investigate the association of Atg18p with the com-
plex, we examined the effects of Vac14p mutations (below).
The Vac14–ingls mutation disrupts interaction with
yeast Fab1p, Vac7p, and Atg18p
To further examine the molecular consequences of the ingls
Vac14–L156R mutation, we generated the equivalent yeast
mutant, vac14–L149R. The L149R mutation is located in
HEAT repeat 4 (Figure 4A) and does not reduce protein
stability (Figure 4B). The vac14D mutant has grossly enlarged
vacuoles compared with the smaller and multilobed wild-
type vacuoles (Figure 4C). When vac14–L149R is present as
the sole copy of VAC14, vacuole size and morphology are
intermediate between the multilobed wild-type and the
vac14D mutant, consistent with partial loss of function
(Figure 4C).
In a yeast two-hybrid test, vac14p–L149R was defective
in binding Fab1p, Vac7p, and Atg18p, although retaining
normal interaction with Fig4p and with itself (Figure 4D).
vac14p–L149R also failed to coprecipitate with Fab1p–TAP
(Figure 4E). In the presence of vac14p–L149R, Fab1p did not
localize to the vacuole membrane (Figure 4F). Thus, HEAT
repeat 4 is critical for the interaction between Vac14p and
Fab1p and is required for the intracellular localization of
Fab1p.
In contrast, vac14p–L149R did coprecipitate with Fig4p
and with itself (Supplementary Figure S7), indicating that the
Fig4p and Vac14p interaction domains are located in a
different region of Vac14p from the L149 mutation.
To examine the effect of loss of Fab1p from the PI(3,5)P2
regulatory complex, we examined the in vivo levels of
PI(3,5)P2. Under basal conditions, PI(3,5)P2 comprises ap-
proximately 0.04% of total PI lipid in the vac14D strain
expressing wild-type VAC14 from a plasmid. When cells are
exposed to hyperosmotic stress, PI(3,5)P2 increases 10-fold to
approximately 0.5% of total PI lipid within 10min, then
decreases to 0.3% at 20min, and to 0.09% at 30min
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Figure 3 The localization of Fab1p, Fig4p, and Vac14p to the
vacuole membrane requires the presence of all three proteins.
Cells labelled with FM4-64 (red) to visualize the vacuole mem-
brane. (A) Wild-type strains with FAB1–3xGFP, FIG4–3xGFP,o r
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this wild-type strain compared with a more typical 20-fold
increase may be a consequence of the expression of VAC14
from a plasmid rather than from its chromosomal location.)
In the vac14D strain expressing vac14–L149R, PI(3,5)P2
comprises 0.03% of the PI lipid under basal conditions
and increases only two-fold to 0.06% after 10min of hyper-
osmotic stress. Thus, dissociation of Fab1p from the complex
through loss of interaction between Vac14p and Fab1p results
in defective activation of Fab1 lipid kinase activity in re-
sponse to hyperosmotic shock. That the modest increase in
PI(3,5)P2 is sustained for at least 30min suggests that regula-
tion of Fig4p lipid phosphatase activity may also be impaired
by the loss of association of Fab1p and Vac14p.
The fab1-2 mutant reveals that activation of Fab1p
requires its association with the Vac14p complex
We sought to identify a mutation in Fab1p that disrupted its
interaction with Vac14p, and found that the fab1-2 mutant
(Yamamoto et al, 1995) is speciﬁcally defective in this inter-
action. We sequenced the mutant fab1-2, and identiﬁed a
single missense mutation, G864E, in the CCT domain
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Figure 4 The vac14–L149R mutant is defective in its association with Fab1p. (A) Schematic of the vac14–L149R mutant. Red asterisk: mutation
site. (B) vac14–L149R protein is stable. Cell lysates from a vac14D strain expressing pRS413–VAC14-HA or pRS413–vac14–L149R–HA (L4R)
analysed by western blot. Vac14p detected with anti-HA antibody. Loading control: Pgk1. (C) vac14–L149R mutant retains partial function.
Vacuoles in the vac14–L149R mutant are intermediate in size between vac14D and wild-type vacuoles. Vacuoles visualized with FM4-64 (red).
vac14D strain transformed with pRS413–VAC14, pRS413–vac14–L149R (vac14-L4R), or pRS413 (vector). (D) Yeast two-hybrid test of Vac14p or
vac14p–L149R interaction with itself, Fab1p, Fig4p, Vac7p, and Atg18p. Full-length Vac14p or vac14p–L149R (vac14-L4R) fused with Gal4-AD
and Gal4-BD. Full-length Fig4p; Atg18p; amino acids 394–918 of Vac7p, amino acids 538–1085 of Fab1p, fused with Gal4-BD. Upper panel, SC-
LEU-TRP (control); lower panel, SD-LEU-TRP-ADE-HISþ3AT (test). (E) Pull-down of Fab1p–TAP coprecipitates wild-type Vac14p, but not
vac14p–L149R. Detergent-solubilized extracts from a vac14D or vac14D/FAB1–TAP strain expressing pRS413–VAC14–HA (WT), or pRS413–
vac14–L149R–HA (L4R). Vac14p but not vac14p–L149R binds Fab1p–TAP IgG beads. (F) Fab1p localization is defective in the vac14p–L149R
mutant. A vac14D/FAB1–3XGFP strain transformed with pRS413–VAC14 or pRS413–vac14–L149R (vac14-L4R). FM4-64 (red), Fab1p–3xGFP
(green). (G) The vac14–L149R mutant does not increase its levels of PI(3,5)P2 in response to hyperosmotic stress. vac14D cells expressing
pRS413–VAC14 or pRS413–vac14–L149R were labelled with [
3H]inositol for 16h and exposed to 0.9M NaCl for times indicated. Values are the
percentage of total extracted [
3H]PI. Error bars: s.d. (n¼3).
VAC14 complex in yeast and ingls mouse
N Jin et al
&2008 European Molecular Biology Organization The EMBO Journal VOL 27 | NO 24 | 2008 3227(Figure 5A). The mutant protein is stable in vivo (Figure 5B)
and retains normal kinase activity in vitro (Supplementary
Figure S8). The CCT domain of Fab1p shares homology with
the GroEL and the CCT family of Hsp60 chaperones, suggest-
ing that it could be involved in protein–protein interactions.
The G864E mutation is located within Fab1p peptide 538–
1085, which interacts with Vac14p in a yeast two-hybrid test
(Figure 2C and 5C). We therefore tested the effect of this
mutation on the interaction between Fab1 and Vac14. In the
yeast two-hybrid test, fab1–G864E does not interact with
VAC14 (Figure 5C). Wild-type Fab1p coimmunoprecipitates
with Vac14p–Venus, but the Fab1p–G864E mutant does not
(Figure 5D). Thus, the G864E mutation disrupts interaction of
Fab1p with Vac14p.
Fab1p coimmunoprecipitates with Fig4p–3XGFP
(Figure 5E). However, the Fab1p–G864E mutant protein
does not coprecipitate with Fig4p–3XGFP (Figure 5E). This
further supports the model that interaction of Fab1p with
G864E
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Figure 5 Formation of a ternary complex of Fab1p, Vac14p, and Fig4p is required for Fab1p kinase activity in vivo.( A) Schematic of the fab1-2
allele; purple asterisk, the G864E mutation. (B) Fab1-2 protein is present at wild-type levels. Cell lysates analysed by western blot analysis from
fab1D cells expressing pRS416–FAB1 or pRS416–fab1-2. Equal protein loaded. (C) VAC14 interacts with FAB1, but not fab1-2. Yeast two-hybrid
test of FAB1 or fab1-2 interaction with VAC14. Full-length VAC14 fused with Gal4-AD. FAB1 or fab1-2, amino acids 538-1085. fused with Gal4-
BD. Upper panel, SC-LEU -TRP (control); lower panel, SC-LEU-TRP-ADE-HISþ3AT (test). Plates incubated at 241C for 4 days. (D–E) fab1-2
does not form a complex with Vac14p and Fig4p. (D) Vac14p–Venus does not coprecipitate fab1-2. pRS416–FAB1 or pRS416–fab1-2 expressed in
a fab1D/VAC14–Venus strain. (E) ﬁg4p–3xGFP does not coprecipitate fab1-2. pRS416–FAB1 or pRS416–fab1-2 expressed in a fab1D/FIG4–
3xGFP strain. (F) fab1-2, Vac14p and Fig4p in a fab1-2 mutant do not localize to the vacuole membrane. pRS416–FAB1–3xGFP or pRS416–fab1-
2–3xGFP expressed in fab1D,o rfab1D/VAC14–Venus or fab1D/FIG4–3xGFP. Cells labelled with FM4-64 (red). (G) The fab1-2 mutant does not
transiently increase its levels of PI(3,5)P2 in response to hyperosmotic stress. fab1D cells expressing pRS416–FAB1 or pRS416–fab1-2 measured
as described in Figure 4. Error bars: s.d. (n¼3).
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Vac14p (Supplementary Figure S4E and F). These coprecipi-
tation results are similar to those observed for fab1p–T1017I,
another point mutation in the CCT domain (Botelho et al,
2008).
The fab1-2 mutant protein fails to localize to the vacuole
membrane (Figure 5F). Localizations of Vac14p–Venus and
Fig4p–3xGFP to the vacuole membrane are also defective in
the presence of fab1-2 protein (Figure 5F). Formation of the
ternary complex thus appears to be required for correct
localization of each component.
To determine the importance of formation of the ternary
complex for the hyperosmotic stress-induced activation of
Fab1p, we tested the effect of osmotic stress on PI(3,5)P2
levels in the fab1-2 mutant. In the wild-type strain, the basal
levels of PI(3,5)P2, 0.05% of total PI lipid, increase 20-fold to
1.15% within 10min after hyperosmotic stress, then decrease
to 0.32% at 20min and 0.11% at 30min (Figure 5G,
Supplementary Table S1). In the fab1-2 mutant, the basal
levels of PI(3,5)P2, 0.033%, increased only two-fold after
10min, similar to the vac14–L149 mutant described above.
These data support the conclusion that association with the
complex is required for the hyperosmotic stress-induced
activation of Fab1p and for the physiological regulation of
PI(3,5)P2 levels.
The vac14-2 mutant disrupts interaction with Vac7p and
Atg18p and results in defective activation and inhibition
of Fab1p
Vac7p is a major activator of yeast Fab1p, and basal levels of
PI(3,5)P2 are signiﬁcantly reduced in a vac7D mutant, result-
ing in enlarged vacuoles (Bonangelino et al, 1997; Duex et al,
2006b). We screened for gain-of-function mutations of
Vac14p that could rescue the low levels of PI(3,5)P2 and
reduce the enlarged vacuoles in vac7D cells. Random PCR
mutagenesis of VAC14 was performed and the mutants were
transformed into a vac14D, vac7D strain. Mutants that re-
stored growth at 371C and partially corrected the enlarged
vacuoles were isolated. When the strongest of these mutants,
vac14-2, was expressed in a vac14D strain, vacuole size was
smaller than in wild-type cells (Figure 6A), suggesting that
PI(3,5)P2 level is increased in this mutant. Direct measure-
ment demonstrated a two-fold increase of the basal level of
PI(3,5)P2 in the vac14-2 mutant (Figure 6B, Supplementary
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Figure 6 Vac7p and Atg18p function through Vac14p. (A) vac14-2 has smaller than normal vacuoles, consistent with elevated basal levels of
PI(3,5)P2. vac14D cells expressing pRS416–VAC14 or pRS416–vac14-2 labelled with FM4-64. (B) vac14-2 has higher basal levels of PI(3,5)P2, but
does not elevate or turnover PI(3,5)P2 during osmotic stress. PI(3,5)P2 levels in vac14D cells expressing pRS416–VAC14 or pRS416–vac14-2
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with hyperosmotic stress, the level of PI(3,5)P2 increased
only 1.7-fold, compared with an 8-fold increase in the wild-
type strain (Figure 6B). There was no change in the steady-
state level of vac14-2 protein compared with wild type
(Figure 6C). The abnormal regulation of PI(3,5)P2 thus
appears to be caused by altered function of the vac14-2
protein.
In a yeast two-hybrid test, vac14 -2 is speciﬁcally defective
in interaction with Vac7p and Atg18p (Figure 6D). Interaction
of vac14-2 protein with Vac14p, Fig4p, and Fab1p is normal
and formation of the ternary complex is unaffected. The
vac14-2 protein also coprecipitates Fab1p to the same extent
as wild-type Vac14p (Figure 6E).
vac14-2 contains four mutations: H56Y, R61K, Q101R, and
L329I (Figure 6F). Three of these mutations, H56, R61, and
Q101, are located in HEAT repeat loops 2 and 3. These
residues exhibit evolutionary conservation. Tested singly in
a yeast two-hybrid test, each mutation perturbed the interac-
tion of Vac14p with Vac7p and Atg18p, without disrupting
interaction with its other binding partners (not shown). Thus
all three residues are important for Vac14p interaction with
Vac7p and Atg18p. L329 alone had no effect on the inter-
action of Vac14p with its known binding partners (data not
shown). These results indicate that HEAT repeats 2 and 3
directly contact Vac7p and Atg18p, but do not contact Fab1.
The elevation in basal levels of PI(3,5)P2 in the vac14-2
mutant is consistent with the model that negative regulation
of Fab1p by Atg18p requires binding of Atg18p to Vac14p.
Whereas the yeast two-hybrid test detected interaction of
Atg18p with Vac14p, this was not observed in pull-down
experiments. Thus, it is informative that a mutation in
Vac14p that interrupts its ability to interact with Atg18p
also results in PI(3,5)P2 levels that are consistent with a
partial release of Atg18p inhibition of Fab1p. The vac14-2
mutant provides additional support for the hypothesis that
Atg18p interacts with Vac14p.
The vac14-2 defect in osmotic stress-induced elevation of
PI(3,5)P2 supports the model that Vac7p, a positive regulator
of Fab1p, exert an effect through binding to Vac14p. The
association of Vac7p with wild-type Vac14p was demon-
strated in the yeast two-hybrid test and by coimmuno-
precipitation (Figure 2C, E).
The Fig4p-binding site on Vac14p is distinct from the
Fab1p-, Vac7p-, and Atg18p-binding sites
Fab1p and Vac7p bind near the N terminus of Vac14p. On the
basis of the predicted HEAT motifs of Vac14p, we divided the
protein into two overlapping constructs (Figure 7). HEAT
repeats 1–10 interact with Fab1p and Vac7p but not with
Fig4p. HEAT repeats 10–21 interact only with Fig4p. These
results demonstrate that Fab1p and Vac7p bind to the
N-terminal half of Vac14p, whereas Fig4p binds to a distinct
site in the C-terminal half. Atg18p binds full-length Vac14p
but does not bind to either half of the molecule. On the basis
of the vac14-2 mutant, we predict that contact points for
Atg18p include the intrarepeat loops of HEATrepeats 2 and 3.
Discussion
Here, we present support for the model that Fab1, Vac14, and
Fig4 form a ternary complex. While this article was in
preparation, independent evidence for formation of this
complex in yeast was reported (Botelho et al, 2008). Our
present studies signiﬁcantly extend those studies by our
discovery that the complex is nucleated by Vac14.
Moreover, analysis of the new, partially functional fab1 and
vac14 mutants demonstrate that the yeast complex includes
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Figure 7 Yeast two-hybrid analysis of the minimal region of Vac14p required for interaction with Fab1p, Fig4p, Vac7p, and Atg18p. Lines above
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include Atg18p, an inhibitor of Fab1p. We ﬁnd that both
Vac7p and Atg18p exert an effect through direct contact with
Vac14p. Our analysis strongly suggests that the organization
of the complex produces dynamic, stimulus-induced changes
in PI(3,5)P2, by three distinct mechanisms. First, the activator
Vac7p and the inhibitor Atg18p bind to overlapping sites,
close to the site of Fab1p. This arrangement could facilitate
the rapid activation and inactivation of the Fab1p lipid kinase
during hyperosmotic stress in yeast. Second, Fab1p and Fig4p
bind simultaneously to nonoverlapping sites on Vac14p,
bring them into close proximity, so that the lipid kinase and
phosphatase share access to the same pools of PI3P and
PI(3,5)P2. Third, the close proximity of Fab1p and Fig4p is
also consistent with our earlier postulate that Fig4p may
function as a protein phosphatase to activate Fab1p by
dephosphorylation (Duex et al, 2006b).
Vac14 contains multiple HEAT repeats
The partial loss of function of Vac14 in the ingls mouse
prompted us to evaluate the molecular function of this
uncharacterized protein. Our bioinformatics analysis pre-
dicted that both the yeast and mammalian Vac14 proteins
are composed entirely of HEATrepeats. Tandem HEATrepeats
form a super-helical structure that provides docking sites for
other proteins. The most common protein–protein docking
sites are the intrarepeat loops (Groves et al, 1999; Xing et al,
2006). Three point mutations in vac14-2 that impair protein
interaction are located in predicted intrarepeat loops, R61K
and H56Y in HEAT 2 and Q101R in HEAT 3. The location in
the intrarepeat loops of three, random independent mutations
that alter protein interactions supports the prediction of the
HEAT repeat structure of Vac14. Analysis of the vac14-2
mutant also indicates that Vac7p and Atg18p bind overlap-
ping sites that include the intrarepeat loops of HEAT repeats
2 and 3.
A second potential protein–protein interaction site is on a
face formed by the B helices of HEAT repeats (Chook and
Blobel, 1999; Cingolani et al, 1999). The helices provide both
structure and points of protein–protein contact. The ingls
mutation is located on the predicted B helix of HEAT 4. This
mutation affects the binding of Fab1p and also impairs
binding of Atg18p and Vac7p. The Fab1p-, Atg18p-, and
Vac7p-binding sites may overlap, or the vac14–L149R muta-
tion may perturb the surrounding structure, altering the
Fab1p-binding site and a separate Atg18p/Vac7p-binding
site. The overlap of Atg18p and Vac7p sites at a position
close to the Fab1p-binding site is consistent with competitive
regulation of Fab1p by its positive and negative regulators.
Vac14 is a scaffold for the Fab1 kinase complex
As HEAT repeats mediate protein–protein interactions, we
investigated and found that Vac14p nucleates the assembly of
a complex containing the proteins that synthesize and turn
over PI(3,5)P2. The location of the vac14–L149R and vac14-2
mutations near the N-terminal region of Vac14p indicates that
the N-terminal half of Vac14p binds Fab1p, Vac7p, and
Atg18p. Indeed, in a yeast two-hybrid test, HEAT repeats
1–10 of Vac14p were sufﬁcient to bind Fab1p and Vac7p
(Figure 7). Conversely, HEAT repeats 10–21 of Vac14p were
sufﬁcient to bind Fig4p (Figure 7). Thus, Fab1p, Fig4p, and
two additional Fab1p regulatory proteins all directly contact
Vac14p and make a large complex that regulates both the
synthesis and turnover of PI(3,5)P2.
The composition of the PI(3,5)P2 regulatory complex
facilitates dynamic regulation of PI(3,5)P2
The fab1-2 mutation disrupts the ability of Fab1p to interact
with Vac14p and prevents coprecipitation of Fab1p with
Fig4p. Negative two-hybrid test results (not shown) suggest
that Fab1p and Fig4p do not interact directly. Fab1p binds to
the N terminus and Fig4p binds to the C terminus of Vac14p.
We propose that Vac14p assumes a conformation that brings
Fab1p into close proximity to Fig4p (Figure 8). This physical
proximity may explain our previous evidence that the lipid
phosphatase Fig4p is an activator of the Fab1p kinase,
possibly through dephosphorylation of the Fab1 protein.
Importantly, the phosphatase activity of Fig4p is required
for its regulatory function; an active site mutant that retains
interaction with Vac14p is nonetheless defective in elevation
of PI(3,5)P2 levels (Bonangelino et al, 1997; Duex et al,
2006b). Fig4p may also contribute to Fab1p activation
through stabilization of the regulatory complex.
In addition to both the lipid phosphatase and lipid kinase,
the PI(3,5)P2 regulatory complex includes a second pair of
proteins with opposing effects on PI(3,5)P2 levels: a lipid
kinase activator and inhibitor. The close association of each
of these proteins in a complex may be key to the rapid
modulation of PI(3,5)P2 levels in vivo (Duex et al, 2006a).
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Figure 8 Model of the Vac14 complex. (A) Schematic Vac14. (B)
Vac14p binds to both Fab1p and Fig4p and may undergo a con-
formational change that brings Fab1p into contact with Fig4p. Fig4p
functions as both an activator of Fab1p and a PI(3,5)P2 5-phospha-
tase. Fig4p and Fab1p bind to distinct regions on Vac14p. The
Fab1p-binding site signiﬁcantly overlaps with Vac7p- and Atg18p-
binding sites. Blue arrowheads indicate the vac14-2 mutations sites,
the arrow to the left indicates the location of H56Y and R61K, the
arrow to the right marks Q101R. These arrows show the region of
Vac14p that contacts Vac7p and Atg18p. Red asterisk indicates the
vac14-ingls mutation, which disrupts interaction with Fab1p, Vac7p,
and Atg18p.
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provides new insights into the acute regulation of PI(3,5)P2
levels. First, the Fab1p lipid kinase and Fig4p lipid phospha-
tase reside in the same complex and bind to opposite ends of
Vac14p. A conformational change in Vac14p could simulta-
neously affect the activities of the kinase and phosphatase in
opposite directions, amplifying the net effect on PI(3,5)P2.
Second, the complex contains both an activator and an inhi-
bitor of Fab1p, Vac7p, and Atg18p, respectively, which bind to
the same region of Vac14p, and most likely bind close to Fab1p.
Again, an altered conformation of Vac14p could result in
opposite effects on binding of the two proteins, amplifying
the effect of either one alone on Fab1p activity. Third, Fig4p has
a dual function and is both a lipid phosphatase and an activator
of the lipid kinase. The structure of the protein complex is most
likely to facilitate the rapid ﬂux in PI(3,5)P2 levels that occurs
in response to various biological stimuli.
PI(3,5)P2 is required for neural function and
pigmentation
Similar to the null mutations of mouse Fig4 and Vac14 (Chow
et al, 2007; Zhang et al, 2007), the Vac14–ingls mutation
results in reduced intracellular levels of PI(3,5)P2, cytoplas-
mic vacuolization, neurodegeneration, and early lethality. As
the Vac14-null mouse dies perinatally, defects in nervous
system function were inferred solely from the histopathology
of newborn mice. The ingls mouse lives up to 3 weeks,
permitting direct observation of abnormal neurological func-
tion, pigmentation, and growth defects. The Vac14–ingls mice
develop a tremor and motor incoordination exempliﬁed by
ataxic gait and difﬁculty in righting. Although the steady-
state levels of Vac14–ingls protein are normal and interaction
with Fig4 is retained, binding of Fab1 is abolished. The failure
of the corresponding yeast mutant to activate Fab1 strongly
suggests that failure of ingls Vac14–L156R to activate mam-
malian Fab1 accounts for the low level of PI(3,5)P2 in
ﬁbroblasts from the ingls mouse. The data suggest that
dissociation of Fab1 from the PI(3,5)P2 regulatory complex
is the molecular basis for neurodegeneration and lethality in
the ingls mouse. Thus, the ability of Vac14 to nucleate the
complete PI(3,5)P2 regulatory complex is essential for normal
neural function.
Differences between the Vac14–ingls, Vac14-null and Fig4-
null mice are listed in Supplementary Table S2. DRG neurons
are severely affected in the Fig4- and Vac14-null mice, but are
spared in the Vac14–ingls mutant. This rescue of sensory
neurons may be explained by their greater capacity for
synthesis of PI(3,5)P2, or by a higher abundance of down-
stream effector proteins. The Vac14–ingls mutant exhibits
astrocytosis with earlier onset and greater severity than the
other mutants, which merits further investigation.
Hydrocephalus is also more severe in the ingls mice, with
huge distention of the ventricles. Differences in the abun-
dance of interacting proteins may account for the cell-type-
speciﬁc effects of these mutations. The mixed-strain back-
grounds of the two null mutants may also contribute to
phenotypic differences from the congenic C57BL/6J.ingls
mice discussed here.
Defects of PI(3,5)P2 regulation and human disease
Mutations of human FIG4 result in the peripheral neuropathy
Charcot–Marie–Tooth type 4J, with features similar to those
in the Fig4-null mouse (Chow et al, 2007). To determine
whether mutations of Vac14 could contribute to Charcot–
Marie–Tooth disorder, we screened the previously described
cohort of 95 patients for variants of VAC14. No variants in
coding sequence or splice sites of VAC14 were observed
(C Chow, M Meisler, M Khajavi, K Szigeti and JR Lupski,
unpublished data). We also investigated the function of
VAC14 in the human neurological disorder SCA4, which
maps to a region of chromosome 16q22 that contains the
VAC14 gene (Flanigan et al, 1996). We sequenced the exons
of VAC14 in an affected member of the original SCA4 family,
but did not detect any coding or splice site mutations
(C Chow, M Meisler, and Y-H Fu, unpublished data). Thus,
the contribution of VAC14 mutations to human disease
remains unknown. Extensive gliosis in patients with
Alexander disease is caused by mutation of GFAP;i ti s
possible that VAC14 or FIG4 could contribute to other dis-
orders characterized by gliosis. The lack of DRG defects in the
ingls mice, in contrast to the previously described null
mutants, suggests that VAC14 could have an important func-
tion in human neurological disorders that are restricted to the
CNS and have not yet been tested.
Evolutionary conservation of PI(3,5)P2 regulation
Our study used the cognate mutation in yeast to provide
molecular insight into the pathology of the ingls mouse. This
work indicates that the activation of Fab1 by the Vac14
complex is conserved from yeast to mammals and is essential
for nervous tissue function, pigmentation and viability. Vac14
nucleates assembly of the PI(3,5)P2 core regulatory complex
in yeast and serves as a scaffold for the complex (Figure 8).
Loss of interaction between Vac14 and Fab1 results in the
lethal neurological disorder in ingls mice. Analysis of the
ingls mutation enabled us to localize the Fab1-interaction
domain of Vac14. In yeast, the vac14–ingls mutation also
disrupts interaction with Vac7p, a positive regulator of Fab1p,
and Atg18p, a negative regulator. The mammalian homolo-
gue of Vac7p has not been identiﬁed, whereas four distinct
homologues of Atg18p are present in the mammalian gen-
ome: WIPI 1–4. Further work will be required to identify all
components of the mammalian PI(3,5)P2 regulatory complex
and to determine the functions of PI(3,5)P2. Thus far, we
have described pathological mutations in the core compo-
nents Fig4 and Vac14 (Chow et al, 2007; Zhang et al,2 0 0 7 ;
this article). Heterozygous mutations of human FAB1 cause
the mild eye phenotype corneal ﬂeck dystrophy (OMIM
609414). In view of the vulnerability of neurons to alteration
of PI(3,5)P2 levels, mutations in other components of the
PI(3,5)P2 regulatory complex are likely to contribute to
human neurological disease.
Materials and methods
Animals
The ingls mutation arose at The Jackson Laboratory in 1991 on the
inbred strain DBA/2J and is maintained as a congenic line on the
C57BL/6J background (current generation F23). Mice are available
from the Jackson laboratory as B6.D2-ingls/J (stock 003095).
Preliminary description of the mutant and its location on chromo-
some 8 was submitted to the Jackson Laboratory website (Bronson
et al, 2003). The Vac14
b geo line was generated from a gene-trap ES
cell from strain 129/Ola, and it lacks detectable protein (Zhang et al,
2007). The gene-trap mice were ﬁrst crossed to strain C57BL/6J and
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b geo mutant has been maintained as a mixed stock
(C57BL/6J X 129/Ola)F12, by mating heterozygotes.
Genotyping
SNP1, CTC AAA CTT CAC CCC (C/T) AGC CCC ACC CCA ACC, is
located at nucleotide 111,611,180 of mouse chromosome 8 (Mouse
Build 37.1, www.ensembl.org) and was genotyped at Kbiosciences
(www.kbioscience.co.uk/software/snpviewer). Mouse Vac14 exon
4 containing the ingls mutation is ampliﬁed with the following
primer pair, designated as Vac14E4: forward, 50CAG CCA GTG GGA
ACA ACC GTG TGA; and reverse, 50 ACA TAG ACA TGC AAG CAG
GCA AAG. These primers are used for genotyping the L156R
mutation by virtue of the loss of a SacI site in the mutant allele
(Figure 1B).
Histology
Tissues were sectioned and stained with H&E at HistoServ
(Germantown, MD). For GFAP staining, mice were perfused with
4% paraformaldehyde, and tissues were sectioned and stained as
described (Liu et al, 2007). Twenty-micrometer cryostat sections
were stained with anti-GFAP (1:1000, rabbit polyclonal, Sigma) and
with secondary antibodies conjugated with biotin (1:200, Vector
Laboratory, Burlingame, CA) followed by avidin–biotin complex
(1:50, Elite, Vector Laboratory). Immunoreactivity was visualized
with diaminobenzidine and 0.02% hydrogen peroxide for up to
5min.
Western blot
For mouse samples, dissected brain cortex was homogenized in
150mM NaCl, 1.0% NP-40, 0.5% deoxycholate, 0.1% SDS, 1mM
EDTA, 50mM Tris–HCl, pH 8.0, with protease inhibitors; Roche
(Cat. no. 11 873 580 001), and lysed on ice for 1h. Molecular weight
markers; Amersham (cat. no. RPN7567). Anti-Vac14 antibody
(Zhang et al, 2007). For yeast samples, experiments were performed
as described previously (Duex et al, 2006b).
Phosphoinositides and vacuoles in cultured cells and yeast
cells
For cultured cells, primary ﬁbroblasts were starved in inositol-free
DMEM 12h and labelled with myo-[2-
3H]inositol, 36h. Lipids were
extracted, deacylated, and analysed by anion-exchange HPLC
chromatography (Zhang et al, 2007). Images of cells were taken
on an Axioscope 2 (Carl Zeiss MicroImaging, Jena, Germany) using
a LUCPlanFL N  40/0.60 Ph2 objective with a DeltaVision
microscope system. For yeast cells, experiments were performed
as described previously (Duex et al, 2006b).
Prediction of HEAT repeat motifs
Seventeen Vac14 sequences analysed were from: S. cerevisiae
(NP_013490.1); Ashbya gossypii ATCC 10895 (NP_984909); Asper-
gillus fumigatus Af293 (XP_751167.1); Kluyveromyces lactis
(XP_454179.1); Yarrowia lipolytica (XP_501232.1); Gibberella zeae
PH-1 (XP_390022.1); Candida glabrata (XP_447078.1); Ustilago
maydis 521(XP_757421.1); Candida albicans SC5314
(XP_716167.1); Neurospora crassa OR74A (XP_959537.1); Debar-
yomyces hansenii CBS767 (XP_456837.1); S. pombe 972h
(NP_596363.1); Cryptococcus var. neoformans B-3501A
(XP_775858.1); Homo sapiens (NP_060522.3); Caenorhabditis
elegans (NP_492215); D. melanogaster (NP_650208); Arabidopsis
thaliana (NP_565275). Potential HEATrepeats in each sequence are
identiﬁed using REP without an applied conﬁdence threshold.
Regions of S. cerevisiae Vac14 with homology to the predicted HEAT
repeat in other species were assumed to form HEAT repeats. The
resulting repeats were further analysed by the secondary structure
prediction program (http://www.bioinf.manchester.ac.uk/dbbrowser/
bioactivity/NPS2.html). Regions predicted to form two helices
connected with a loop were selected. This predicted 21 and 17 HEAT
repeats in S. cerevisiae and human Vac14, respectively. We manually
aligned the human Vac14 sequence with random seed sequences from
the Pfam database and obtained the same 17 repeats.
Fluorescence microscopy
Yeast cells labelled with FM4-64 (Duex et al, 2006a). Fluorescence
and differential interference contrast (DIC) images generated with a
Deltavision system (Applied Precision, WA). Images are processed
using Adobe Photoshop.
Immunoprecipitation in yeast cells
A total of 10 OD log-phase cells were lysed in lysis buffer; 50mM
Tris pH 7.5, 120mM NaCl, 10mM EDTA, 1mM EGTA, 5mM
2-glycerophosphate, 1mM PMSF, 10mM benzamidine, 1mg/ml
leupeptin, 5mg/ml aprotonin. Extracts were spun at 500g to
sediment unbroken cells. Octyl-glucoside (Sigma) was added to the
supernatant to a ﬁnal concentration of 0.5%. Subsequent manip-
ulations were performed at 41C. Resulting extracts were incubated
for 30min and spun at 13000g, 10min. Anti-HA (COVANCE), anti-
GFP (Roche Applied Science) or anti-V5 (Invitrogen) were added to
the supernatant and incubated for 1h. Protein A immobilized on
Sepharose beads (Sigma) was added and incubated for 1h. Protein
complexes bound to the beads were washed seven times with lysis
buffer containing 0.5% octyl-glucoside, then eluted in sample buffer
(50mM Tris, pH6.8, 2% SDS, 5% b-mercaptoethanol, 10% glycerol,
0.01% BPB) at 801C, 5min. SDS–PAGE and western blot analysis
were used to detect Vac14–HA or V5, Vac7, Fab1, Fig4–Myc.
Yeast two-hybrid analysis
VAC14 was subcloned into the XmaI–SalI site of pGAD or pGBD.
FAB1 encoding amino acids 538–1085 was subcloned into the
EcoRI–BglII site of pGBD. VAC7 encoding amino acids 394–918 was
subcloned into SmaI–SalI site of pGBD. ATG18 was subcloned into
the EcoRI–SalI site of pGBD. FIG4 was subcloned into the BamHI–
PstI site of pGBD. Plasmids were cotransformed into the yeast strain
PJ69-4A, transformants were plated onto SC-LEU-TRP, replica-
plated onto SC-LEU-TRP, SC-LEU-TRP-ADE-HISþ3AT, or SC-LEU-
TRP-ADE-HIS and grown for 4–10 days at 241C. The yeast strain
PJ69-4A and the pGAD and pGBD vectors have been described
(James et al, 1996).
Glycerol gradients
A total of 12ml of 10–50% glycerol gradients were prepared in the
lysis buffer with 0.5% octyl-glucoside. S13 lysates were prepared
from 20 OD cells as described above, loaded on the top and spun at
31000r.p.m. for 18h at 41C. Fractions (1ml) were precipitated with
TCA, and 1/10 of the sample was separated by SDS–PAGE.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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